Cite
HARVARD Citation
Hoppe, C. et al. (2016). Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso‐Occlusive Events) trial: A global Phase 3 double‐blind, randomized, placebo‐controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy. Pediatric blood & cancer. 63 (2), pp. 299-305. [Online].